Amazon.com (AMZN) is terminating its contract with Progyny (PGNY), a company that sells fertility benefits such as in vitro fertilization and egg freezing to employers, Bob Herman of STAT reports, citing a source familiar with the matter. Starting January 1, 2025, Amazon employees will no longer have access to Progyny’s services, according to STAT. Instead, Amazon will use Maven as its fertility benefits vendor, a source told the website. Progyny disclosed on Wednesday the loss of “significant client” but did not mention Amazon.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PGNY:
- Progyny price target lowered to $18 from $24 at Canaccord
- Jefferies lowers Progyny price target to $24, calls selloff ‘excessive’
- Playtika to acquire SuperPlay, Intel says not selling Mobileye: Morning Buzz
- Morning Movers: Darden rises following first quarter results
- Progyny price target lowered to $26 from $33 at Truist